Referred to the House Committee on Energy and Commerce.
The bill directs the EPA Administrator to revise 40 C.F.R. §61.206 within two years to establish a process for approving distribution or use of phosphogypsum for purposes not already permitted under §§61.204–61.205. It requires applicants to submit maximum individual lifetime cancer-risk estimates, plans to minimize exposure to workers and nearby residents, and detailed surface- and groundwater leachate and ecotoxicity assessments plus a quarterly monitoring program.
Risk tolerance: progressives view reopening approvals as unsafe; conservatives see potential economic and waste-management benefits.
Relative to its intended legislative type, this bill is a clear administrative/operational directive that sets a deadline for EPA to revise a specific regulatory provision and prescribes substantive submission requirements and a numeric risk ceiling for approvals.
The bill directs the EPA Administrator to revise 40 C.F.R. §61.206 within two years to establish a process for approving distribution or use of phosphogypsum for purposes not already permitted under §§61.204–61.205.
It requires applicants to submit maximum individual lifetime cancer-risk estimates, plans to minimize exposure to workers and nearby residents, and detailed surface- and groundwater leachate and ecotoxicity assessments plus a quarterly monitoring program.
Approvals must be made on a case-by-case basis, may not exceed a maximum individual risk of 9.1 in 100,000 over a 70-year lifetime, and supporting data and test results must be posted publicly on EPA’s website.
On content alone, the bill is narrowly targeted and administratively implementable, which improves its chance relative to sweeping measures. Its technical safeguards (risk cap, monitoring, public disclosure) reduce some opposition, but because it affects radioactive-material policy and could be perceived as easing environmental protections, it may face organized resistance and committee hurdles; success is plausible but far from assured without negotiated compromises or inclusion in a broader legislative vehicle.
Relative to its intended legislative type, this bill is a clear administrative/operational directive that sets a deadline for EPA to revise a specific regulatory provision and prescribes substantive submission requirements and a numeric risk ceiling for approvals. It provides concrete items that must be included in requests and requires public posting and monitoring, but it does not supply methodological standards, resource or funding recognition, procedural rules for approval decisions, or enforcement mechanisms.
Risk tolerance: progressives view reopening approvals as unsafe; conservatives see potential economic and waste-management benefits.
These are examples from the analysis, not a ranked list of the most-affected groups.
Risk tolerance: progressives view reopening approvals as unsafe; conservatives see potential economic and waste-management benefits.
A mainstream progressive would approach this bill with caution.
They would note that the bill retains a cancer-risk ceiling and requires monitoring and public disclosure, but would be concerned that it opens the door to approving uses of a radioactive industrial byproduct that EPA previously banned because of health and environmental risks.
They would worry about cumulative exposures, worker safety, environmental justice implications for nearby communities, and whether the EPA would have the resources and authority to enforce strict safeguards.
A pragmatic moderate would see this bill as an attempt to replace a categorical prohibition with a structured, evidence-based approval process.
They would appreciate the risk ceiling, public disclosure, and monitoring requirements, which enable measured reuse if it is demonstrably safe.
At the same time they would be concerned about whether EPA will have clear, enforceable standards and sufficient resources to evaluate and monitor applications and about the adequacy of the 9.1-in-100,000 threshold for diverse exposure scenarios.
A mainstream conservative would generally welcome removing categorical impediments to reusing an industrial byproduct, viewing the bill as a move toward enabling beneficial reuse and reducing waste management burdens.
They would value the case-by-case approach and the codification of a clear numerical risk ceiling rather than an across-the-board ban.
However, they may object to some of the administrative and testing burdens the bill mandates and could prefer a faster, less prescriptive approval process.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone, the bill is narrowly targeted and administratively implementable, which improves its chance relative to sweeping measures. Its technical safeguards (risk cap, monitoring, public disclosure) reduce some opposition, but because it affects radioactive-material policy and could be perceived as easing environmental protections, it may face organized resistance and committee hurdles; success is plausible but far from assured without negotiated compromises or inclusion in a broader legislative vehicle.
The bill has not accumulated any surfaced votes yet.
Risk tolerance: progressives view reopening approvals as unsafe; conservatives see potential economic and waste-management benefits.
On content alone, the bill is narrowly targeted and administratively implementable, which improves its chance relative to sweeping measures…
Relative to its intended legislative type, this bill is a clear administrative/operational directive that sets a deadline for EPA to revise a specific regulatory provision and prescribes substantive submission requireme…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.